Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center - Report - MDSpire
Advertisement
Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center
Clinical Report: Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease
Overview
This study evaluates the integration of double-balloon enteroscopy (DBE) into the diagnostic pathway for suspected small bowel Crohn’s disease, highlighting the diagnostic yield of small bowel capsule endoscopy (SBCE) and factors influencing DBE referral. The findings suggest that SBCE is effective for initial assessment, while DBE is reserved for cases requiring further histological confirmation.
Background
Small bowel Crohn’s disease poses diagnostic challenges, often leading to delayed treatment. SBCE offers a non-invasive means to visualize the small bowel, but lacks the ability to obtain histological samples. DBE serves as a complementary tool, enabling direct assessment and therapeutic interventions, thus improving patient management in suspected cases of Crohn’s disease.
Data Highlights
Outcome
Result
SBCE performed as initial investigation
90.8%
Direct DBE for therapeutic/histological reasons
5.5%
SBCE-to-DBE conversion rate
30.4%
SBCE diagnostic yield for inflammatory bowel disease
70%
DBE confirmed Crohn’s disease
21%
DBE excluded Crohn’s disease
79%
Key Findings
SBCE established or excluded inflammatory bowel disease in 70% of patients.
DBE confirmed Crohn’s disease in 21% of patients referred after SBCE.
Increasing age and diagnostic uncertainty on SBCE were significant predictors for DBE referral.
The SBCE-to-DBE conversion rate was 30.4%.
DBE should be reserved for cases requiring histological confirmation or therapeutic intervention.
Clinical Implications
Clinicians should consider SBCE as the first-line diagnostic tool for suspected small bowel Crohn’s disease due to its high diagnostic yield. DBE is indicated for patients with uncertain SBCE findings or those needing histological confirmation, thereby optimizing patient management and minimizing unnecessary procedures.
Conclusion
The integration of SBCE and DBE enhances the diagnostic pathway for small bowel Crohn’s disease, allowing for effective triage and targeted interventions. This approach may lead to improved patient outcomes through timely diagnosis and treatment.